Product Description
The global electromyogram monitoring market was valued at $290 million in 2024. This is expected to increase over the forecast period at a CAGR of 2.4% to reach over $343 million.
The full report suite on the global market for electromyogram (EMG) monitoring includes EMG monitors and EMG consumables.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2021
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL ELECTROMYOGRAM MONITORING MARKET TRENDS
The demand for EMG devices is expanding into newer areas, such as the operating room (OR) and rehabilitation, and this has opened up additional opportunities for EMG procedures to be performed. The market for EMG devices may see future growth as a result of continuing expansion into new areas of hospitals and alternate care sites. Furthermore, many countries worldwide are experiencing rapid improvements to their overall healthcare infrastructure, which is allowing for greater numbers of patients to be treated each year.
GLOBAL ELECTROMYOGRAM MONITORING MARKET SHARE INSIGHTS
- Natus Medical was the clear leader of the EMG monitoring market. The company continues to increase its market share through the acquisition of other companies. Natus Medical manufactured the Dantec Keypoint®, Nicolet® EDX and VikingQuest® EMG devices, which offer a range of applications including diagnostic EMG, nerve conduction studies (NCSs), evoked potentials (EPs) and intra-operative electro-monitoring (IOM) functionality. The Nicolet® and Viking™ EMG systems, originally part of CareFusion’s portfolio, continue to see success as part of the Natus Medical brand. It is respected because of its long history of reliability and quality engineering. The VikingQuest® is notable as it offers a highly portable EMG solution.
- Nihon Kohden was the second-leading competitor in the EMG monitoring market with a modest market share in 2024. Its Neuropack™ product line offers the X1, S1 and S3 series of devices, each with different channel configurations. All monitors include EP and EMG measuring capabilities and may be accompanied by a variety of optional software packages for expanded functionality. Additionally, the units are capable of integrating with Nihon Kohden’s electroencephalogram (EEG) amplifier to provide for a complete neurodiagnostic solution. The devices feature Windows®-based applications, of which many users are already familiar and comfortable with.
- Cadwell Laboratories is the third-leading competitor in the EMG monitoring market, thanks to its significant share in the North American market. Cadwell Laboratories boasts a history of being responsible for the first microprocessor-controlled EMG device, which was created in 1979 by John Cadwell. Cadwell’s Sierra® Summit™ is the newest addition to the Sierra® line and can be equipped with a two-, six- or twelve-channel amplifier.
GLOBAL ELECTROMYOGRAM MONITORING MARKET SEGMENTATION SUMMARY
- EMG Monitors
- EMG Consumables – Further Segmented Into:
- Device Type: Concentric Needle, Monopolar Needle, and Surface Electrodes.
GLOBAL RESEARCH SCOPE
Report Attribute | Details |
---|---|
Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
Base Year | 2024 |
Forecast | 2025-2031 |
Historical Data | 2021-2023 |
Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |